안구건조증 치료제 시장(2025년) : 세계 분석(2024-2030년)

The "2025 Dry Eye Pharmaceuticals Market Report" provides a comprehensive analysis of the global market for dry eye therapeutics, examining the disease's prevalence, diagnosis, and treatment landscape. The report provides in-depth coverage of artificial tears, anti-inflammatory drops, miticides, tear evaporation inhibitors, mucin secretagogues, and other prescription and over-the-counter products-with detailed forecasts of unit demand, sales revenue, and market performance by region through 2030.

The report offers a data-driven assessment of the current dry eye marketplace and its growth potential, highlighting new product development, emerging drug-delivery methods, and the expanding pharmaceutical pipeline. Global and regional forecasts are presented for seven major regions, with coverage of competitive dynamics, regulatory differences, and therapeutic trends. Profiles are provided for 23 leading companies and their strategic positioning within the dry eye market.

Contents:

The "2025 Dry Eye Pharmaceuticals Market Report" evaluates the evolving market for prescription and over-the-counter therapies used in the management of dry eye disease. The report combines epidemiological data, disease characterization, and five-year market projections to outline future opportunities in one of ophthalmology's fastest-growing categories.

The following topics are covered in the report:

• Comprehensive overview of dry eye disease: anatomy of normal tear function, symptoms, risk factors, diagnostic criteria, and DEWS classification
• Prevalence and risk analysis: regional estimates and risk profiles for the US, Western Europe, Japan, China, India, Latin America, and other global markets
• Diagnosis and care trends: approaches to diagnosis, regional practice variations, and severity segmentation
• Treatment pathways and product segmentation: analysis of lubricants, anti-inflammatories, and sustained-release therapeutics
• Global and regional market forecasts: unit demand, revenue forecasts, market share by product type and company, and consumption trends through 2030
• Pharmaceutical pipeline analysis: detailed review of more than 30 investigational compounds and emerging drug-delivery technologies
• Profiles of major competitors: in-depth profiles of 23 leading dry eye pharmaceutical manufacturers, including their portfolios, strategies, and outlook